Stock Analysts

Pacira Q4 & 2014 Revenues to Come In Line with Estimates

Pacira Pharmaceuticals, Inc. ( PCRX ) provided its revenue estimates for fourth-quarter and full-year 2014, both of which are in line with the Zacks Consensus Estimate. Pacira expects revenues of $61.8 million in the fourth quarter of 2014, an increase of 84% year over year and in line with the Zacks Consensus Estimate […]

Stock Analysts

Impax Soars on FDA Nod of Parkinson’s Disease Drug Rytary

Impax Laboratories Inc ’s ( IPXL ) shares jumped 11.7% and attained a 52-week high on the FDA approval of Rytary, an extended-release oral capsule formulation of carbidopa-levodopa. The FDA has approved Rytary for the treatment of patients suffering from Parkinson’s disease and post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication. We note that Rytary’s approval path has not exactly been smooth with the company receiving a complete response letter for the drug in Jan 2013. […]

Stock Analysts

Should Headwaters (HW) Stock be in Your Portfolio Now?

On Jan 9, 2015, Zacks Investment Research upgraded Headwaters Incorporated ( HW ) to a Zacks Rank #1 (Strong Buy). Why the Upgrade? Headwaters has not only witnessed a rise in its share price but also upward revision in its earnings estimates on account of recovery in the residential housing and R&R (repair and remodel) end markets, and a favorable EPA ruling. […]

Stock Analysts

Will Affordable US Houses Hurt Private Mortgage Insurers?

In a new drive to make home buying more affordable, President Obama announced yesterday that annual mortgage premiums charged by the Federal Housing Administration (“FHA”) will be trimmed by 50 basis points – from 1.35% to 0.85%. The reduction in mortgage premium will slash the annual mortgage payment for new home buyers as well as existing home owners. As a result, creditworthy families that can afford a home but have been shut out of the market because of tight lending requirements will be hugely benefited. […]